Condition

Stage I Breast Cancer AJCC v7

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 20 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials20
Recruiting2
Common interventions25
Lead sponsors shown9
Advertisement

Clinical trials

20 shown
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069 · 2022-08-18
RECRUITING
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyNCT02945579 · 2017-01-20
RECRUITING
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy AdherenceNCT04054557 · 2019-07-31
COMPLETED
SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast CancerNCT03411070 · 2019-04-07
COMPLETED
Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer SurvivorsNCT03407716 · 2019-03-01
COMPLETED
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast SurgeryNCT03317405 · 2018-10-31
ACTIVE_NOT_RECRUITING
The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast CancerNCT03454529 · 2018-03-09
COMPLETED
Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After SurgeryNCT03324802 · 2018-02-07
COMPLETED
Kindness Interventions in Enhancing Well-Being in Breast Cancer SurvivorsNCT03319342 · 2017-07-11
COMPLETED
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast CancerNCT03077841 · 2017-03-06
SUSPENDED
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast CancerNCT02912312 · 2017-02-23
ACTIVE_NOT_RECRUITING
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerNCT02954874 · 2017-01-18
ACTIVE_NOT_RECRUITING
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast CancerNCT02598557 · 2016-12-06
COMPLETED
Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBCNCT02593175 · 2016-11-03
COMPLETED
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast CancerNCT02689427 · 2016-09-22
COMPLETED
Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer TreatmentNCT02754752 · 2016-09-13
ACTIVE_NOT_RECRUITING
Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After SurgeryNCT02654119 · 2015-12-11
COMPLETED
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot InitiativeNCT02276443 · 2015-11-09
ACTIVE_NOT_RECRUITING
Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast CancerNCT03568526 · 2015-07-02
COMPLETED
Radiation Therapy in Treating Patients With Stage 0-II Breast CancerNCT01245712 · 2010-11-15
ACTIVE_NOT_RECRUITING

Common interventions

Trial status mix

COMPLETED11
ACTIVE_NOT_RECRUITING6
RECRUITING2
SUSPENDED1

Phase mix

PHASE29
NA5
PHASE33
EARLY_PHASE12
PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.